IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,721,600 | -64.9% | 60,000 | -68.3% | 0.04% | -69.6% |
Q2 2023 | $7,754,670 | +26.7% | 189,000 | +10.4% | 0.14% | +16.9% |
Q1 2023 | $6,118,688 | +89.5% | 171,200 | +100.2% | 0.12% | +131.4% |
Q4 2022 | $3,229,335 | -33.6% | 85,500 | -22.3% | 0.05% | -23.9% |
Q3 2022 | $4,866,000 | -34.3% | 110,000 | -45.0% | 0.07% | -34.3% |
Q2 2022 | $7,404,000 | +91.6% | 200,000 | +57.5% | 0.10% | +131.8% |
Q4 2021 | $3,864,000 | -51.2% | 127,000 | -46.2% | 0.04% | -51.1% |
Q3 2021 | $7,916,000 | -46.3% | 235,993 | -36.1% | 0.09% | -53.1% |
Q2 2021 | $14,732,000 | +446.0% | 369,307 | +515.5% | 0.19% | +231.0% |
Q1 2021 | $2,698,000 | -82.1% | 60,000 | -77.5% | 0.06% | -83.1% |
Q4 2020 | $15,108,000 | +39.6% | 267,227 | +17.2% | 0.34% | +36.0% |
Q3 2020 | $10,819,000 | -29.0% | 228,000 | -11.7% | 0.25% | -50.1% |
Q2 2020 | $15,228,000 | +162.4% | 258,276 | +186.0% | 0.51% | +73.6% |
Q2 2019 | $5,804,000 | -31.9% | 90,300 | -14.0% | 0.29% | -37.9% |
Q1 2019 | $8,523,000 | – | 105,000 | – | 0.47% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |